print version 

Find company
Home About the ProjectContact usFor the Clients
Enter code or ISIN
 
alpha / industry search

Issuers' Corner
Press Releases
Annual Reports Library

Financial Statements
SEC & FFMS Filings
Corporate Presentations
GM Materials
Issues Documents
Corporate Governance Materials
Russian Company Guide
Company Profiles
Corporate Calendar
Markets Corner
Consensus Estimates
Media Corner
News Line


Get updates



Home  Issuers' Corner  Press Releases REGISTER LOG IN

Press Releases

company search
all press releases
all Pharmstandard press releases

Pharmstandard

January 18, 2011

OJSC Pharmstandard-Leksredstva announces tender offer for 4.9% of Pharmstandard ordinary shares

Moscow, 18 January, 2011 – OJSC Pharmstandard-Leksredstva (the “Company”) is pleased to announce an offer to purchase up to 1,850,000 shares of OJSC Pharmstandard (“Pharmstandard”), representing about 4.9% of Pharmstandard’s share capital.

The offer is conducted in accordance with the decision of the Company’s sole shareholder dated 18 January, 2011. OJSC Pharmstandard-Leksredstva is a wholly-owned subsidiary of OJSC Pharmstandard.

Under the terms of the offer, shareholders are invited to sell part or all of their holdings in Pharmstandard at a price of 3000 Russian Rubles per ordinary share. The offer will commence at 16:00, Moscow Time, on January 18, 2011 and expire at 18:30, Moscow time, on February 16, 2011, unless extended by the Company. On February 18, 2011, based on the review of the submitted applications to sell shares (“ofertas”), OJSC Pharmstandard-Leksredstva will indicate to the shareholders, which submitted ofertas, the number of shares allocated to them by the Company.

In line with its strategy Pharmstandard continues to look for opportunities to increase its market capitalisation through acquisitions and organic growth. The decision to return cash to shareholders through buy back of Pharmstandard shares by the Company is consistent with Pharmstandard’s commitment to maintain an appropriate capital structure and a disciplined approach to returning excess capital to shareholders.

With overall low leverage (total outstanding credit debt of USD 12,9 million at December 31, 2010) and effective cash flow management Pharmstandard remains well positioned to fund its growth strategy.

All relevant documents relating to the offer, including the Offer Memorandum, are available at http://www.e-disclosure.ru/ and http://www.pharmstd.ru/investors_en/investor/offer_memorandum/

Pharmstandard management is pleased to invite investors and media to participate in a conference call to discuss the offer, which will include a Q&A session.

Conference Call with Pharmstandard Management
Tender Offer by Pharmstandard-Leksredstva for 4.9% of Pharmstandard Ordinary Shares

Thursday, 20 January, 2011

09:00 AM New York time
02:00 PM London time
05:00 PM Moscow time

Dial In Numbers:
Russia Free Call 8108 002 411 2044
UK Standard International +44 (0) 1452 550 733
USA Free Call 1877 741 8062

Please dial-in 5 to 10 minutes ahead of the scheduled start time.

 

 

 

Search by industry

Agriculture, Foresty and Fishing | Chemicals | Engineering | Ferrous Metals | Financial, Insurance & Real Estate | Food & Kindred Products | General Construction | Information Technology | Media & Publishing | Non-Ferrous Metals | Oil & Gas | Pharmaceuticals | Power Industry | Precious Metals and Diamonds | Telecommunications | Transportation | Wholesale & Retail Trade

Search by alpha index

A B C D F G I K L M N O P R S T U V W X Z


Site Map
© RUSTOCKS.com
Privacy Statement | Disclaimer